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Editorial on the Research Topic
Innovative Technologies and Clinical Applications for Invasive and Non-invasive
Neuromodulation: From theWorkbench to the Bedside
Invasive and non-invasive brain stimulation represent one of the most promising scientific
advances of the last decades (1). This special issue was designed to highlight and critically discuss
innovative neurostimulation procedures for Parkinson’s disease (PD) and other neurological
conditions. Of the 17 papers initially submitted to the journal by international researchers, 13
were considered suitable for publication after a thorough peer-review process. These included five
original researches, five reviews, one systematic review, one brief research report, and one case
report. The following is a short summary of the main results of each of these manuscripts.
Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN), the ventral-intermediate
nucleus (VIM), and the globus pallidus pars interna (GPi) are well-established therapeutic options
for medically refractory PD, essential tremor, and dystonia (2, 3). However, several aspects related
to DBS programming and post-surgical management of medications still remain to be clarified. In
their manuscript, Koeglsperger et al. provide a concise review of strategies for DBS programming
and dopaminergic medications adjustments following DBS. In another review from the same
group, by Hell et al., summarizes and carefully discusses future perspectives for DBS, including
target identification, adaptive closed-loop stimulation, and associated feedback signals.
Although STN- and GPi-DBS are both considered effective in reducing levodopa-induced
dyskinesia (LID), the comparative efficacy of the two targets on dyskinesia remains unclear. Liu
et al. conducted a meta-analysis of studies reporting data on STN- and GPi-DBS efficacy on LID.
The authors found that GPi-DBS may reduce dyskinesia to a higher extent than STN-DBS at
12 months. This observation implies that mechanisms for dyskinesia reduction may be different
between STN- and GPi-DBS. Future studies are needed to clarify the complex biological interaction
with different systems of fibers involved in the modulation of motor symptoms in the two most
common targets for DBS in the basal ganglia.
STN-DBS may also have a beneficial effect on balance and gait in PD. However, published
results yielded variable conclusions. In their prospective controlled study, Szlufik et al. evaluated
the impact of STN-DBS on balance disorders in PD. The authors found a beneficial effect of
STN-DBS on static and dynamic instability in the short-term follow-up, while long-term data
remain controversial. Zhang et al., report the case of a PD patient implanted with STN-DBS
and complaining of severe speech problems. Tremor and speech problems were both effectively
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treated by a novel stimulation procedure, i.e., variable-
frequency stimulation (VFS) consisting of a combination of high
frequencies. This preliminary observation should be confirmed
in future controlled studies. Again, concerning the possible
detrimental effects of DBS, the review paper titled: “A Review
of Cognitive Outcomes Across Movement Disorder Patients
Undergoing Deep Brain Stimulation,” by Cernera et al. discuss
the issue of DBS-associated cognitive declines and adverse
effects on quality of life in PD and other movement disorders.
Pathophysiological mechanisms for cognitive changes occurring
after DBS are also discussed.
Non-invasive neuromodulation, including Transcranial
Magnetic Stimulation (TMS), in movement disorders is a
challenging issue for both clinical and research purposes (4–6).
Various non-invasive brain stimulation protocols have been
studied in different conditions and settings. Hence, the reliability
and validity of non-invasive neuromodulation techniques are
still to be elucidated. In this regard, various methodological
factors, possibly influencing the outcome measure, need to
be better investigated. Fricke et al. developed an associative
dual-site rTMS (1Hz) targeting the premotor and primary
motor cortex. The protocol aimed to activate different cortico-
basal ganglia projections and, therefore, to target pathogenic
oscillations at distinct STN subregions. The study results
demonstrate that the stimulation was tolerated well, but did
not improve motor symptoms in PD. Even though results
were negative, this study raises interest toward non-invasive
treatment options for PD symptoms. Furthermore, negative
therapeutic results should not discourage the use of non-invasive
stimulation techniques as a tool to investigate pathophysiological
mechanisms underlying movement disorders. For example,
dystonia is a relatively frequent movement disorder with unclear
pathophysiology. However, the cerebellum is now considered a
key area in the generation of dystonic symptoms. Odorfer et al.
combined non-invasive cerebellar stimulation, i.e., continuous
theta-burst stimulation and functional magnetic resonance
imaging techniques, and investigated simple finger tapping
in patients with cervical dystonia. Results indicate that finger
movements, although clinically normal, are associated with
altered cerebellar activity, further supporting the hypothesis
of a prominent cerebellar involvement in dystonia. Finally, it
should be considered that non-invasive stimulation techniques
also allow to investigate physiological aspects not necessarily
involved in the motor control. For example, mesial cortical
areas in the frontal lobe and the ventral striatum are key nodes
involved in decision-making and executive functions. In their
original research study, including neuroimaging techniques,
Popa et al. demonstrate how deep inhibitory rTMS can influence
the underlying network functional connectivity of the targeted
mesio-prefrontal-cingulo-striatal circuits regions. The study
emphasizes that the modulation of resting neural activity in
mesial prefrontal-striatal circuits by non-invasive techniques as
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a potential therapeutic tool for a wide range of psychiatric and
neurologic disorders, particularly drug-cue reactivity processes
relevant to addiction.
An increasing number of studies on animals and humans
suggest that both the peripheral and the central nervous
system can be targeted and potentially modulated by ultrasound
stimulation techniques (7). An important aspect concerns the
possibility to suppress or facilitate ongoing neural activity
(during stimulation), as well as to induce long-lasting effects
or even tissue ablation. In their review paper, di Biase et al.
summarize mechanisms of actions, stimulation parameters, and
therapeutic application of Transcranial Ultrasound Stimulation
(tUS) in healthy humans and various disease states. In their
original research article, Gibson et al. demonstrate that tUS
delivered via a commercially available diagnostic imaging
ultrasound system transiently increases excitability in the motor
cortex. The results raise the intriguing possibility of new clinical
applications for this technology, mainly as a diagnostic imaging
for neuroplasticity induction not only in the motor cortex, but
also in other brain areas. This initial but promising results
encourage further research studies.
Alternative non-invasive stimulation techniques, like Spinal
Cord Stimulation (SCS) and Non-Invasive Focal Mechanical
Vibrations (NIFMV), may also improve motor control in
different neurological diseases (8, 9). The review paper by
Fonoff et al. summarizes the most relevant advances from
experimental and clinical studies, including anecdotal reports,
on SCS for gait disorders. The author discusses the potential
mechanisms of action, neural substrates, and clinical outcomes
of SCS, suggesting that gait abnormalities in parkinsonian
syndromes, particularly freezing of gait, can improve with
SCS. However, the authors acknowledge that future well-
designed trials are needed to delineate the possible therapeutic
applications for SCS. The results of the pilot open-label trial
by Schirinzi et al. indicate that NIFMV represents a feasible,
safe, and effective option of supportive therapy for patients
with cerebellar ataxia. More extensive controlled studies are
necessary to confirm these preliminary observations and to
define other critical methodological aspects related to treatment
and eligibility criteria.
In conclusion, the editors wish to thank all the authors, the
reviewers, and the editorial board members for contributing to
this special issue. We hope that this special issue might inspire
future and novel research approaches in the field of invasive and
non-invasive neuromodulation in Parkinson’s disease and other
movement disorders.
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